Table 1.
Effectiveness of the intervention on the proportion of subjects with undetected viral load (≤20 copies/ml) (N = 246)
| Intervention | Control | P-value | |||
|---|---|---|---|---|---|
| Number with undetected viral load (%) | Change over 12 months (E12–E0) |
Number with undetected viral load (%) | Change over 12 months (E12 – E0) | ||
| At baseline | 26/119 (21.8%) | – | 54/127 (42.5%) | – | < 0.001 |
| At 12 months | 38/119 (31.9%) | 10.1% | 52/127 (40.9%) | −1.6% | 0.15 |
| At 12 months adjusteda | 28/77 (36.4%) | 14.6% | 27/56 (48.2%) | 5.7% | 0.12 |
aAdjusted for study participants with regimen change to Dolutegravir-based combination